BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 24811151)

  • 21. Quality assurance procedures for mass spectrometry untargeted metabolomics. a review.
    Dudzik D; Barbas-Bernardos C; García A; Barbas C
    J Pharm Biomed Anal; 2018 Jan; 147():149-173. PubMed ID: 28823764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Overview on the Importance of Combining Complementary Analytical Platforms in Metabolomic Research.
    Gonzalez-Dominguez A; Duran-Guerrero E; Fernandez-Recamales A; Lechuga-Sancho AM; Sayago A; Schwarz M; Segundo C; Gonzalez-Dominguez R
    Curr Top Med Chem; 2017; 17(30):3289-3295. PubMed ID: 29231141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NMR-based metabolomics: a probe to utilize biodiversity.
    Pimenta LP; Kim HK; Verpoorte R; Choi YH
    Methods Mol Biol; 2013; 1055():117-27. PubMed ID: 23963907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sample preparation methods for LC-MS-based global aqueous metabolite profiling.
    Beltran A; Samino S; Yanes O
    Methods Mol Biol; 2014; 1198():75-80. PubMed ID: 25270923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolomics as a promising tool for early osteoarthritis diagnosis.
    de Sousa EB; Dos Santos GC; Duarte MEL; Moura V; Aguiar DP
    Braz J Med Biol Res; 2017 Sep; 50(11):e6485. PubMed ID: 28953990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combining NMR and LC/MS Using Backward Variable Elimination: Metabolomics Analysis of Colorectal Cancer, Polyps, and Healthy Controls.
    Deng L; Gu H; Zhu J; Nagana Gowda GA; Djukovic D; Chiorean EG; Raftery D
    Anal Chem; 2016 Aug; 88(16):7975-83. PubMed ID: 27437783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current metabolomics: technological advances.
    Putri SP; Yamamoto S; Tsugawa H; Fukusaki E
    J Biosci Bioeng; 2013 Jul; 116(1):9-16. PubMed ID: 23466298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances and challenges in development of precision psychiatry through clinical metabolomics on mood and psychotic disorders.
    Pedrini M; Cao B; Nani JVS; Cerqueira RO; Mansur RB; Tasic L; Hayashi MAF; McIntyre RS; Brietzke E
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jul; 93():182-188. PubMed ID: 30904564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Unknown Metabolomics Mixture Compounds by Combining NMR, MS, and Cheminformatics.
    Leggett A; Wang C; Li DW; Somogyi A; Bruschweiler-Li L; Brüschweiler R
    Methods Enzymol; 2019; 615():407-422. PubMed ID: 30638535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolomics and dereplication strategies in natural products.
    Tawfike AF; Viegelmann C; Edrada-Ebel R
    Methods Mol Biol; 2013; 1055():227-44. PubMed ID: 23963915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The future of NMR-based metabolomics.
    Markley JL; Brüschweiler R; Edison AS; Eghbalnia HR; Powers R; Raftery D; Wishart DS
    Curr Opin Biotechnol; 2017 Feb; 43():34-40. PubMed ID: 27580257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of a two-step quality control approach for a large-scale human urine metabolomic study conducted in seven experimental batches with LC/QTOF-MS.
    Demetrowitsch TJ; Petersen B; Keppler JK; Koch A; Schreiber S; Laudes M; Schwarz K
    Bioanalysis; 2015; 7(1):103-12. PubMed ID: 25558939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Challenges of analyzing different classes of metabolites by a single analytical method.
    Mirnaghi FS; Caudy AA
    Bioanalysis; 2014; 6(24):3393-416. PubMed ID: 25534794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-resolution plant metabolomics: from mass spectral features to metabolites and from whole-cell analysis to subcellular metabolite distributions.
    Kueger S; Steinhauser D; Willmitzer L; Giavalisco P
    Plant J; 2012 Apr; 70(1):39-50. PubMed ID: 22449042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knowns and unknowns in metabolomics identified by multidimensional NMR and hybrid MS/NMR methods.
    Bingol K; Brüschweiler R
    Curr Opin Biotechnol; 2017 Feb; 43():17-24. PubMed ID: 27552705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Harnessing metabolomics for nutrition research.
    Zulyniak MA; Mutch DM
    Curr Pharm Biotechnol; 2011 Jul; 12(7):1005-15. PubMed ID: 21466460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liquid chromatography-mass spectrometry in metabolomics research: mass analyzers in ultra high pressure liquid chromatography coupling.
    Forcisi S; Moritz F; Kanawati B; Tziotis D; Lehmann R; Schmitt-Kopplin P
    J Chromatogr A; 2013 May; 1292():51-65. PubMed ID: 23631876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NMR and MS Methods for Metabolomics.
    Amberg A; Riefke B; Schlotterbeck G; Ross A; Senn H; Dieterle F; Keck M
    Methods Mol Biol; 2017; 1641():229-258. PubMed ID: 28748468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Recent development of metabonomics and its applications in clinical research].
    Li H; Jiang Y; He FC
    Yi Chuan; 2008 Apr; 30(4):389-99. PubMed ID: 18424407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preprocessing and Pretreatment of Metabolomics Data for Statistical Analysis.
    Karaman I
    Adv Exp Med Biol; 2017; 965():145-161. PubMed ID: 28132179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.